Generic Name : Ticagrelor Pronunciation : tye-KA-grel-or Therapeutic Classification : Anticoagulants / Antithrombotics ICD Code : Y44.2
International- Brilinta Why it is prescribed (Indications) :
This medication is a platelet aggregation inhibitor, prescribed for reducing death rate in patients with myocardial infarction and angina pectoris. It works by preventing platelets from collecting and forming clots. When it is not to be taken (Contraindications): Contraindicated in patients with severe liver problems, active bleeding, stroke, and hypersensitivity.
Dosage & When it is to be taken :
Adult- PO- The recommended initial dose is 180 mg (two 90 mg tablets) and continue treatment with 90 mg twice daily. How it should be taken :
It comes as a tablet to take by mouth with or without food. Warnings and Precautions :
* Caution should be exercised in patients with history of lung, liver or kidney disease, stomach or bowel bleeding, recent injury, irregular heartbeat, stroke, gout, who are taking other medications, any allergy, elderly, children, during pregnancy and breastfeeding.
* It may cause dizziness, do not drive a car or operate machinery while taking this medication.
* It may reduce platelet counts; avoid injury or bruising. Side Effects :
Difficulty in breathing, headache, cough, dizziness, nausea, abnormal heart rhythm, high blood pressure, chest pain, diarrhea, back pain, low blood pressure, fatigue and chest pain.
* Avoid excess dosage. Storage Conditions :
Store it at controlled room temperature (25- 30°C).
Comment & Contribute
Ask an Expert